NBC Los Angeles1mon
FDA says the Zepbound shortage is over. Here's what that means for compounding pharmacies, patients who used off-brand versions - NBC Los Angeles
the active ingredient in Eli Lilly's weight loss drug Zepbound, is no longer in short supply. That decision will largely prevent compounding pharmacies from making and selling cheaper versions of ...
Becker's Hospital Review27d
Eli Lilly to join lawsuit over GLP-1 shortage: 4 things to know
Eli Lilly is intervening in a lawsuit filed by a trade group representing compounding pharmacies, aiming to block the FDA's determination that the shortage of its GLP-1 medications, Mounjaro and ...
JD Supra2d
The GLP-1 Saga Continues: FDA Ends the Tirzepatide Shortage: Frequently Asked Questions
FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...
Eli Lilly Shares Fall After GLP-1 Sales Miss Expectations. Is the Stock in Trouble?
When investors are paying such high price tags for a stock, expectations are high, and any kind of miss can result in a steep ...
The Hill27d
Pharma giant seeks to join lawsuit against FDA over weight loss drugs
Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by joining as a defendant, stating it wants to end the “entitlement” some ...
NBC 10 Philadelphia1mon
FDA says the Zepbound shortage is over. Here's what that means for compounding pharmacies, patients who used off-brand versions - NBC10 Philadelphia
the active ingredient in Eli Lilly's weight loss drug Zepbound, is no longer in short supply. That decision will largely prevent compounding pharmacies from making and selling cheaper versions of ...
NBC 7 San Diego1mon
FDA says the Zepbound shortage is over. Here's what that means for compounding pharmacies, patients who used off-brand versions
the active ingredient in Eli Lilly's weight loss drug Zepbound, is no longer in short supply. That decision will largely prevent compounding pharmacies from making and selling cheaper versions of ...